Talis Biomedical Corporat... (TLIS)

1.68

-0.32 (-16.00%)

At close: Feb 28, 2025, 9:30 AM

0.00

-100.00%

After-hours: Dec 31, 1969, 07:00 PM EST

Talis Biomedical Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-62.01M	-113.01M	-192.04M	-91.13M	-27.47M	-21.34M
Depreciation & Amortization	770K	8.83M	1.58M	763K	726K	647K
Stock-Based Compensation	4.35M	5.37M	9.21M	3.68M	965K	679K
Other Working Capital	-1.25M	-6.37M	8.61M	91K	455K	-1.53M
Other Non-Cash Items	7.07M	6.36M	1.04M	611K	817K	3.37M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.42M	-7.69M	8.82M	-951K	640K	-932K
Operating Cash Flow	-53.24M	-100.14M	-171.38M	-87.02M	-24.33M	-20.94M
Capital Expenditures	-486K	-1.61M	-2.87M	-8.2M	-578K	-533K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-486K	-1.61M	-2.87M	-8.2M	-578K	-533K
Debt Repayment	n/a	n/a	n/a	n/a	15M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	33K	406K	1.88M	246.75M	24.61M	8K
Financial Cash Flow	33K	406K	234.43M	246.75M	39.61M	8K
Net Cash Flow	-53.69M	-101.34M	60.18M	151.53M	14.71M	-21.47M
Free Cash Flow	-53.73M	-101.75M	-174.25M	-95.22M	-24.9M	-21.48M